Truvian
PrivateLast Round
VC Round
Jul 17, 2024
Total Funding Raised
$176.3M
Company Overview
Truvian is a healthcare technology company that develops an automated benchtop blood testing platform designed to provide lab-accurate diagnostic results in decentralized care settings.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Truvian Comparables
Compare Truvian with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vital | 92% | |
| Genalyte | 85% | |
| Osler Diagnostics | 85% |
Truvian Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 17, 2024 | ||||
| Debt | Sep 14, 2021 | ||||
| Series C | Feb 24, 2021 | ||||
| Series B | Nov 20, 2019 | ||||
| Series A | Sep 1, 2017 |
Key People
Founding team and executive leadership
Truvian Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GreatPoint Ventures | Series C, VC Round, Series B |
| Wasson Enterprise | Series C |
| Pacific West Bank | Debt |
| Domain Associates | Series B, Series A |
| GreatPoint Ventures | Series C, Series B |
| Medical Excellence Capital | VC Round |
| General Catalyst | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2025
Proprietary blood testing platform is currently under FDA review.
- Jan 13, 2025
Developing a comprehensive benchtop solution for blood testing.
Truvian Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Truvian's valuation, stock price, and market status.
Is Truvian a public or private company?
Truvian is a private company.
What is the current stock price of Truvian?
Truvian is a private company with no public stock price. No recent secondary market data is available.
How much is Truvian worth (valuation)?
Valuation information for Truvian is not publicly available.
Can I buy Truvian stock?
Truvian shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Truvian's last funding round?
Truvian's most recent funding round was VC Round on July 17, 2024.
Who are the main investors in Truvian?
Key investors in Truvian include GreatPoint Ventures, GreatPoint Ventures, Wittington Ventures, TYH Ventures, George Weston Limited.
Will Truvian IPO soon?
No public IPO plans have been announced for Truvian.
How can I track Truvian secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Truvian's secondary market activity and sign up for updates.